U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680738) titled 'Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis' on June 23.
Brief Summary: Multiple sclerosis (MS) is a chronic, inflammatory and disabling disease of the Cnetral Nervous System characterized by relapsing and / or progressive somatosensory, motor and vestibular clinical manifestations. Moreover, fatigue, depression, anxiety, and cognitive impairment are also present in most MS patients. These symptoms substantially impact quality of life and often show limited response to conventional pharmacological treatment.
Transcranial direct current stimulation (tDCS) is a non-invasive technique ...